Last reviewed · How we verify
NCT04099043: CASPA
Cascade CGM 15-day Performance Assessment
NA trial testing Cascade Continuous Glucose Monitoring System in Continuous Glucose Monitoring in 10 participants. Completed in 13 October 2019.
13 October 2019
Quick facts
| Lead sponsor | WaveForm Technologies Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 10 |
| Start date | 28 September 2019 |
| Primary completion | 13 October 2019 |
| Estimated completion | 13 October 2019 |
| Sites | 1 location across Slovenia |
Drugs / interventions tested
- Cascade Continuous Glucose Monitoring System
Conditions studied
- Continuous Glucose Monitoring — all drugs for Continuous Glucose Monitoring →
Sponsor
WaveForm Technologies Inc.
Who can join
18 and older, any sex, with Continuous Glucose Monitoring. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To validate the feasibility of a 15-day wear period of the Cascade CGM system
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A Prospective Multicenter Clinical Performance Evaluation of the C-CGM System.
Rebec M, Cai K, Dutt-Ballerstadt R, Anderson E. · · 2022 · cited 10× · PMID 33084416 · DOI 10.1177/1932296820964574
Verify or expand the search:
- PubMed search for NCT04099043
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Continuous Glucose Monitoring
Currently open trials in the same condition.
- NCT07097415 — The Application of Continuous Blood Glucose Monitoring in Optimizing the Management of Type 2 Diabetes · NA · recruiting
- NCT06648174 — The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus · NA · recruiting
- NCT06641765 — Continuous Glucose Monitoring in Dialysis Patients With Diabetes · NA · active not recruiting
- NCT06716671 — Influence of Continuous Glucose Monitoring on Quality of Life in People With Type 2 Diabetes Mellitus · active not recruiting
- NCT06436326 — The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes · NA · recruiting
Other WaveForm Technologies Inc. trials
Trials by the same sponsor.
- NCT05460260 — Glucomen Day Cascade CGM System 21-Day Wear Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04099043 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by WaveForm Technologies Inc.
- Last refreshed: 6 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04099043.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing